PT1355641E - Utilizacao de (r)-ibuprofen-metanossulfonamida e os seus sais no tratamento e prevencao das reaccoes de rejeicao de orgaos transplantados - Google Patents
Utilizacao de (r)-ibuprofen-metanossulfonamida e os seus sais no tratamento e prevencao das reaccoes de rejeicao de orgaos transplantadosInfo
- Publication number
- PT1355641E PT1355641E PT02719742T PT02719742T PT1355641E PT 1355641 E PT1355641 E PT 1355641E PT 02719742 T PT02719742 T PT 02719742T PT 02719742 T PT02719742 T PT 02719742T PT 1355641 E PT1355641 E PT 1355641E
- Authority
- PT
- Portugal
- Prior art keywords
- prevention
- treatment
- transplanted
- ibuprofen
- methanosulfonamide
- Prior art date
Links
- 238000006243 chemical reaction Methods 0.000 title abstract 4
- 230000002265 prevention Effects 0.000 title abstract 3
- -1 (R) -IBUPROFEN-METHANOSULFONAMIDE Chemical compound 0.000 title 1
- URZONQSEPBBTSB-HNCPQSOCSA-N methanesulfonamide;(2r)-2-[4-(2-methylpropyl)phenyl]propanoic acid Chemical compound CS(N)(=O)=O.CC(C)CC1=CC=C([C@@H](C)C(O)=O)C=C1 URZONQSEPBBTSB-HNCPQSOCSA-N 0.000 abstract 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical class NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2001MI000206A ITMI20010206A1 (it) | 2001-02-02 | 2001-02-02 | Uso della metansolfonammide di (r)-ibuprofene e dei suoi sali non tossici per la preparazione di medicamenti per il trattamento e la prevenz |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1355641E true PT1355641E (pt) | 2005-11-30 |
Family
ID=11446717
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT02719742T PT1355641E (pt) | 2001-02-02 | 2002-01-30 | Utilizacao de (r)-ibuprofen-metanossulfonamida e os seus sais no tratamento e prevencao das reaccoes de rejeicao de orgaos transplantados |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US7560487B2 (enExample) |
| EP (1) | EP1355641B1 (enExample) |
| JP (1) | JP2004517948A (enExample) |
| KR (1) | KR100857898B1 (enExample) |
| CN (1) | CN1561205A (enExample) |
| AT (1) | ATE304846T1 (enExample) |
| AU (1) | AU2002250869B2 (enExample) |
| BR (2) | BRPI0206804B1 (enExample) |
| CA (1) | CA2432432C (enExample) |
| CZ (1) | CZ303665B6 (enExample) |
| DE (1) | DE60206245T2 (enExample) |
| DK (1) | DK1355641T3 (enExample) |
| EE (1) | EE05233B1 (enExample) |
| ES (1) | ES2248541T3 (enExample) |
| HU (1) | HU229070B1 (enExample) |
| IL (1) | IL157180A (enExample) |
| IT (1) | ITMI20010206A1 (enExample) |
| MX (1) | MXPA03006686A (enExample) |
| NO (1) | NO334285B1 (enExample) |
| NZ (1) | NZ526655A (enExample) |
| PL (1) | PL215109B1 (enExample) |
| PT (1) | PT1355641E (enExample) |
| RU (1) | RU2257895C2 (enExample) |
| SK (1) | SK287632B6 (enExample) |
| WO (1) | WO2002062330A2 (enExample) |
| ZA (1) | ZA200304861B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602004003673T2 (de) * | 2004-03-25 | 2007-10-04 | Dompe' Pha.R.Ma S.P.A. | Verwendung von N-(2-Aryl-propionyl)-sulfonamiden zur Behandlung von Rückenmarkverletzungen |
| WO2006121995A2 (en) | 2005-05-09 | 2006-11-16 | Tap Pharmaceutical Products, Inc. | Methods for treating nephrolithiasis |
| CA2669935A1 (en) * | 2006-11-13 | 2008-05-29 | Takeda Pharmaceuticals North America, Inc. | Methods for preserving renal function using xanthine oxidoreductase inhibitors |
| EP2308484A1 (en) | 2009-10-06 | 2011-04-13 | Dompé S.p.a. | Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets |
| EP2308485A1 (en) | 2009-10-06 | 2011-04-13 | Dompé S.p.a. | Sulfonamides for the prevention of diabetes |
| JP5978216B2 (ja) | 2010-09-10 | 2016-08-24 | タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド | テオフィリンとフェブキソスタットの併用療法のための方法 |
| US10561676B2 (en) * | 2013-08-02 | 2020-02-18 | Syntrix Biosystems Inc. | Method for treating cancer using dual antagonists of CXCR1 and CXCR2 |
| US10046002B2 (en) | 2013-08-02 | 2018-08-14 | Syntrix Biosystems Inc. | Method for treating cancer using chemokine antagonists |
| HUE065802T2 (hu) * | 2017-03-15 | 2024-06-28 | Numares Ag | Marker-készlet alkalmazása vesekilökõdés kockázatának meghatározására |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4879283A (en) * | 1985-10-03 | 1989-11-07 | Wisconsin Alumni Research Foundation | Solution for the preservation of organs |
| RU2008901C1 (ru) * | 1991-03-29 | 1994-03-15 | Донецкий государственный медицинский институт им.М.Горького | Способ фармакологической защиты децентрализованной почки |
| ATE257389T1 (de) * | 1992-09-17 | 2004-01-15 | Amgen Inc | Pharmazeutische zusammensetzungen mit interleukin-1 inhibitoren |
| IL110296A (en) * | 1993-07-16 | 1999-12-31 | Smithkline Beecham Corp | Imidazole compounds process for their preparation and pharmaceutical compositions containing them |
| JPH08231413A (ja) * | 1994-12-29 | 1996-09-10 | Mochida Pharmaceut Co Ltd | 臓器障害に基づく疾患の予防・治療剤 |
| IT1303249B1 (it) * | 1998-10-23 | 2000-11-06 | Dompe Spa | Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono. |
| US6355682B1 (en) * | 2001-05-11 | 2002-03-12 | Assa Weinberg | Treatment of acute renal failure by administration of N-acetylcysteine |
-
2001
- 2001-02-02 IT IT2001MI000206A patent/ITMI20010206A1/it unknown
-
2002
- 2002-01-30 BR BRPI0206804A patent/BRPI0206804B1/pt unknown
- 2002-01-30 RU RU2003126600/15A patent/RU2257895C2/ru not_active IP Right Cessation
- 2002-01-30 KR KR1020037009714A patent/KR100857898B1/ko not_active Expired - Fee Related
- 2002-01-30 PL PL363576A patent/PL215109B1/pl unknown
- 2002-01-30 EE EEP200300340A patent/EE05233B1/xx not_active IP Right Cessation
- 2002-01-30 PT PT02719742T patent/PT1355641E/pt unknown
- 2002-01-30 AT AT02719742T patent/ATE304846T1/de active
- 2002-01-30 BR BR0206804-4A patent/BR0206804A/pt not_active IP Right Cessation
- 2002-01-30 JP JP2002562337A patent/JP2004517948A/ja active Pending
- 2002-01-30 DE DE60206245T patent/DE60206245T2/de not_active Expired - Lifetime
- 2002-01-30 CA CA002432432A patent/CA2432432C/en not_active Expired - Fee Related
- 2002-01-30 AU AU2002250869A patent/AU2002250869B2/en not_active Ceased
- 2002-01-30 NZ NZ526655A patent/NZ526655A/en not_active IP Right Cessation
- 2002-01-30 ES ES02719742T patent/ES2248541T3/es not_active Expired - Lifetime
- 2002-01-30 CZ CZ20032095A patent/CZ303665B6/cs not_active IP Right Cessation
- 2002-01-30 CN CNA028042263A patent/CN1561205A/zh active Pending
- 2002-01-30 WO PCT/EP2002/000946 patent/WO2002062330A2/en not_active Ceased
- 2002-01-30 EP EP02719742A patent/EP1355641B1/en not_active Expired - Lifetime
- 2002-01-30 SK SK973-2003A patent/SK287632B6/sk not_active IP Right Cessation
- 2002-01-30 MX MXPA03006686A patent/MXPA03006686A/es active IP Right Grant
- 2002-01-30 DK DK02719742T patent/DK1355641T3/da active
- 2002-01-30 HU HU0303024A patent/HU229070B1/hu not_active IP Right Cessation
-
2003
- 2003-01-30 US US10/250,465 patent/US7560487B2/en not_active Expired - Fee Related
- 2003-06-23 ZA ZA200304861A patent/ZA200304861B/en unknown
- 2003-07-18 NO NO20033273A patent/NO334285B1/no not_active IP Right Cessation
- 2003-07-31 IL IL157180A patent/IL157180A/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fox | Silver sulfadiazine—a new topical therapy for pseudomonas in burns: therapy of pseudomonas infection in burns | |
| EE02971B1 (et) | Droloksüfeeni või selle soolade kasutamine luuhaiguste vastase ravimi valmistamiseks | |
| ATE517624T1 (de) | Behandlung von neurodegenerativen erkrankungen und krebs im gehirn | |
| BR9909668A (pt) | Uso de compostos de organofósforo para o tratamento terapêutico e profilático de infecções | |
| BR0111358A (pt) | Compostos de tioacetamida e seu uso | |
| EP1350511A4 (en) | MEDICAL COMPOSITIONS CONTAINING ASPIRIN | |
| BR9908702A (pt) | Composto, processos para inibir sìntese de óxido nìtrico em um paciente, para inibir seletivamente sìntese de óxido nìtrico produzido pela no sintase indutìvel no óxido nìtrico produzido pelas formas constitutivas de no sintase em um paciente e para diminuir nìveis de óxido nìtrico em um paciente, e, composição farmacêutica | |
| DK1001792T3 (da) | Anvendelse af fysiologisk acceptable vanadiumforbindelser, -salte og -komplekser | |
| MXPA03006686A (es) | Uso de metanosulfonamida de ( r ) ibuprofen y sales de la misma en el tratamiento y prevencion de las reacciones de rechazo de organos transplantados. | |
| BR0113062A (pt) | Derivados de heterociclilalquilazol e seu emprego como agente para o combate de parasitas | |
| BR9608506A (pt) | "2-Amino-benzoxazinonas para o tratamento de infeccões viróticas | |
| BR0115883A (pt) | Derivados de ácido amino-furan-2-il-acético e ácido amino-tien-2-il-acético substituìdos e seu emprego para o tratamento de cefaléia ou dor | |
| DE502004005055D1 (de) | Oxaliplatinlösungskonzentrate | |
| ATE344662T1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen | |
| ATE521344T1 (de) | Calciumsalze zur behandlung von psoriasis, dermatitis und schuppen | |
| PT1091746E (pt) | Utilizacao de solucoes salinas isoosmoticas para a preparacao de medicamentos cerumenoliticos | |
| DE602004022783D1 (de) | Heterozyklische harnstoff-derivate für die behandlung von schmerzen. | |
| DK1401448T3 (da) | Antibakterielle behandling af osteoarthrit | |
| EP1325918A4 (en) | INHIBITORS OF CARDIAC MUSCLE CELL APOPTOSIS AND THERAPEUTIC / PROPHYLACTIC AGENTS AGAINST HEART DISEASE | |
| ATE403644T1 (de) | Amidinophenylbrenztraubensäure-derivat | |
| NO20052562L (no) | Anvendelse av distrontiumsalter av 2-[N,N-di(karboksylmetyl)amino]-3-cyano-4-karboksylmetyl-tiofen-5-karboksylsyre for fremstilling av medikamenter for behandlingen av gastro-duodenal smerte. | |
| RU2000125000A (ru) | Состав для антисептической обработки кожи рук и операционного поля | |
| BR0316059A (pt) | Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise | |
| PL1514545T3 (pl) | Zastosowanie tolperyzonu do leczenia skurczów narządów zbudowanych zasadniczo z mięśni gładkich | |
| BR0013921A (pt) | Composições farmacêuticas para tratamento de psorìase |